Starling Oncology (TOI) holder pairs 12K-share buy with call option sale
Rhea-AI Filing Summary
Starling Oncology, Inc. insider Jorey Chernett, a more-than-10% owner, reported mixed transactions in company securities. On 2026-08-14, Chernett purchased 12,000 shares of common stock at $6.54 per share, bringing direct holdings to 10,660,858 shares. On 2026-08-13, Chernett sold 100 call option contracts on Starling Oncology (each linked to 100 shares, or 10,000 underlying common shares) with a $9.00 exercise price and 19-Feb-2027 expiration, at $6.24 per option. According to a footnote, this option sale is treated as a matchable transaction under Section 16(b), and Chernett intends to disgorge the calculated short-swing profit to the issuer.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 12,000 shares
Net Buy
2 txns
Insider
Chernett Jorey
Role
10% Owner
Bought
12,000 shs ($78K)
Sold
100 shs ($624.00)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 12,000 | $6.54 | $78K |
| Sale | Call Option (STLN 19FEB27 $9C) F1 | 100 | $6.24 | $624.00 |
Holdings After Transaction:
Call Option (STLN 19FEB27 $9C) — 0 shares (Direct);
Common Stock — 10,660,858 shares (Direct)
Footnotes (1)
- F1. The sale of these call options is a matchable transaction subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer.
Key Figures
Common shares purchased: 12,000 shares
Purchase price: $6.54 per share
Shares owned after transaction: 10,660,858 shares
+5 more
8 metrics
Common shares purchased
12,000 shares
Open-market purchase of Starling Oncology common stock on 2026-08-14
Purchase price
$6.54 per share
Price paid for 12,000 common shares on 2026-08-14
Shares owned after transaction
10,660,858 shares
Direct common stock holdings following the 2026-08-14 purchase
Call option contracts sold
100 contracts
Sale of call options on STLN on 2026-08-13
Underlying common shares
10,000 shares
Common stock underlying the 100 sold call option contracts
Call option sale price
$6.24 per option
Per-option price for the 100 call option contracts sold on 2026-08-13
Call option exercise price
$9.00 per share
Exercise price of the sold call options expiring 2027-02-19
Call option expiration date
2027-02-19
Expiration of the STLN 19FEB27 $9C call options sold
Key Terms
Section 16(b), short-swing profit, disgorge, call options
4 terms
Section 16(b) regulatory
"The sale of these call options is a matchable transaction subject to Section 16(b)"
A federal rule that requires company insiders—like officers, directors and large shareholders—to return any profits made from buying and selling the company’s stock within a six-month window. It matters to investors because it discourages short-term trades that could exploit non-public information and helps protect outside shareholders by creating a simple, enforceable way to recover unfair gains, much like a rule stopping someone from flipping a limited-edition item for quick profit after getting early access.
short-swing profit regulatory
"calculated a short-swing profit in connection with such matchable transactions"
Short-swing profit is any gain an insider makes from buying and selling (or selling and buying) the same company's stock or options within a six-month window; regulators treat those quick trades as presumptively improper and typically require the profits to be returned. Think of it like flipping a concert ticket for a quick markup — the law prevents insiders with privileged access from keeping those fast gains, which protects ordinary investors and promotes fair markets.
disgorge regulatory
"which the reporting person intends to disgorge to the Issuer"
call options financial
"The sale of these call options is a matchable transaction"
A call option is a contract that gives its buyer the right, but not the obligation, to buy a specific number of shares at a predetermined price within a set time. Think of it like a refundable reservation to purchase a stock later at today’s agreed price: investors use calls to profit from expected price rises with smaller upfront cost than buying the stock outright, or to hedge and manage exposure, while the most they can lose is the amount paid for the contract.
FAQ
What did STLN insider Jorey Chernett buy in this Form 4 filing?
Chernett purchased 12,000 shares of Starling Oncology, Inc. common stock at $6.54 per share on 2026-08-14. Following this open-market purchase, Chernett’s direct ownership increased to 10,660,858 common shares.
What options on STLN did Jorey Chernett sell in this Form 4?
Chernett sold 100 call option contracts on STLN on 2026-08-13 at $6.24 per option. The options reference 10,000 underlying common shares, have a $9.00 exercise price, and expire on February 19, 2027.
What is the significance of Section 16(b) in this STLN Form 4 filing?
A footnote states the call option sale is a matchable transaction under Section 16(b), and Chernett has calculated a short-swing profit that he intends to disgorge to the issuer, Starling Oncology, Inc.
Is the overall trading activity by STLN insider Chernett net buying or selling?
Across the reported transactions, activity is net buying, with 12,000 common shares purchased and 100 option contracts sold. The net share impact, considering option contracts, is summarized as a net-buy of 11,900 shares in the structured data.
AI-generated analysis. How Rhea-AI works. Not financial advice.
